Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites

Nature Medicine

Volumn 10, Issue 10, 2004, Pages 1104-1110

  Zaph, Colby ^a   Uzonna, Jude ^a   Beverley, Stephen M ^b   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HOMING RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELLULAR IMMUNITY; CENTRAL MEMORY T CELL; EFFECTOR CELL; IMMUNE RESPONSE; INFECTION; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; LONG TERM MEMORY; MEMORY CELL; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE ISOLATION; PRIORITY JOURNAL; VACCINATION; VACCINE PRODUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC MEMORY; L-SELECTIN; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; PROTOZOAN VACCINES; TH1 CELLS;

ANIMALIA; LEISHMANIA MAJOR; NEMATODA;

EID: 7044254507     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1108     Document Type: Article

References (41)

1. Reiner, S.L. & Locksley, R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177 (1995).
2. Sacks, D.L. & Noben-Trauth, N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858 (2002).
3. Afonso, L.C. et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237 (1994).
4. Gurunathan, S., Prussin, C., Sacks, D.L. & Seder, R.A. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4, 1409-1415 (1998).
5. Gurunathan, S., Klinman, D.M. & Seder, R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18, 927-974 (2000).
6. Gicheru, M.M. et al. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect. Immun. 69, 245-251 (2001).
7. + T cell responses and protection against Leishmania major infection. J. Exp. Med. 195, 1565-1573 (2002).
8. Desjeux, P. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14, 417-423 (1996).
9. Uzonna, J.E., Wei, G., Yurkowski, D. & Bretscher, P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J. Immunol. 167, 6967-6974 (2001).
10. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507 (2002).
11. Sallusto, F., Lenig, D., Forster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712 (1999).
12. Masopust, D., Vezys, V., Marzo, A.L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
13. Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101-105 (2001).
14. Roman, E. et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196, 957-968 (2002).
15. + effector and memory T cell generation. Nat. Immunol. 4, 835-842 (2003).
16. Kaech, S.M., Hemby, S., Kersh, E. & Ahmed, R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111, 837-851 (2002).
17. Wherry, E.J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225-234 (2003).
18. Bradley, L.M., Watson, S.R. & Swain, S.L. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp. Med. 180, 2401-2406 (1994).
19. Jung, T.M., Gallatin, W.M., Weissman, I.L. & Dailey, M.O. Down-regulation of homing receptors after T cell activation. J. Immunol. 141, 4110-4117 (1988).
20. Picker, L. J. et al. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J. Immunol. 145, 3247-3255 (1990).
21. Zaph, C. & Scott, P. Th1 cell-mediated resistance to cutaneous infection with Leishmania major is independent of P- and E-selectins. J. Immunol. 171, 4726-4732 (2003).
22. Titus, R.G., Gueiros-Filho, F.J., de Freitas, L.A. & Beverley, S.M. Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. USA 92, 10267-10271 (1995).
23. -) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro. Clin. Exp. Immunol. 119, 299-304 (2000).
24. Mocci S. & Coffman, R.L. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154, 3779-3787 (1995).
25. Mocci, S. & Coffman, R.L. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations. J. Immunol. 158, 1559-1564 (1997).
26. Iezzi, G., Scheidegger, D. & Lanzavecchia, A. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J. Exp. Med. 193, 987-993. (2001).
27. Wang, X. & Mosmann, T. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells. J. Exp. Med. 194, 1069-1080 (2001).
28. Lanzavecchia, A. & Sallusto, F. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2, 982-987 (2002).
29. Doyle, A.M. et al. Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells. J. Exp. Med. 194, 893-902 (2001).
30. Gray, D. A role for antigen in the maintenance of immunological memory. Nat. Rev. Immunol. 2, 60-65 (2002).
31. Zinkernagel, R.M. On natural and artificial vaccinations. Annu. Rev. Immunol. 21, 515-546 (2003).
32. Swain, S.L., Hu, H. & Huston, G. Class II-independent generation of CD4 memory T cells from effectors. Science 286, 1381-1383 (1999).
33. Murali-Krishna, K. et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286, 1377-1381 (1999).
34. + T lymphocytes in vivo. J. Immunol. 162, 766-773 (1999).
35. Bunce, C. & Bell, E.B. CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J. Exp. Med. 185, 767-776 (1997).
36. Garcia, S., DiSanto, J. & Stockinger, B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 11, 163-171 (1999).
37. Harbertson, J., Biederman, E., Bennett, K.E., Kondrack, R.M. & Bradley, L.M. Withdrawal of stimulation may initiate the transition of effector to memory CD4 cells. J. Immunol. 168, 1095-1102 (2002).
38. Flynn, J.L. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb.) 84, 93-101 (2004).
39. Desrosiers, R.C. Prospects for an AIDS vaccine. Nat. Med. 10, 221-223 (2004).
40. Scott, P., Pearce, E., Natovitz, P. & Sher, A. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139, 221-227 (1987).
41. Lyons, A.B. & Parish, C.R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131-137 (1994).